Peptides are the latest wellness trend – but do they work?

July 28, 2026 - 03:52

A US drug advisory committee has recently given a nod of approval to several experimental peptides, signaling a potential shift in how these compounds are viewed by regulators. Yet despite the growing buzz, large-scale human trials for these new substances remain absent, leaving significant questions about their safety and effectiveness unanswered.

Peptides, short chains of amino acids that act as building blocks for proteins, have become the latest darling of the wellness industry. They are being marketed for everything from muscle recovery and anti-aging to improved sleep and cognitive function. Proponents claim these tiny molecules can mimic natural processes in the body, triggering specific biological responses without the side effects of traditional drugs.

However, the reality is more complicated. While some peptides have legitimate medical uses, such as in hormone therapies or certain skin treatments, the vast majority sold as wellness supplements have not undergone rigorous testing. The recent advisory committee recommendation applies only to a handful of experimental compounds, not the broad range of products available online or in clinics.

Experts caution that the lack of regulation in the peptide supplement market poses real risks. Products may be contaminated, mislabeled, or contain unknown dosages. Without proper oversight, consumers are essentially acting as test subjects. Until large, controlled studies confirm both the benefits and the potential dangers, the peptide trend remains more hope than proven science.